Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Ulrich Lang has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12806491

ALPHA-AMINO BORONIC ACID DERIVATIVES, SELECTIVE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61K 31/69, C07F 5/02, A61P 37/00
Applicant:
Ares Trading SA
Agent:
Ulrich Lang, Merck KGaA
Status:
GRANT OF PATENT INTENDED
EP13724172

IMIDAZO-OXADIAZOLE AND IMIDAZO-THIADIAZOLE DERIVATIVES

IPC classification:
A61K 31/506, A61K 31/4439, A61K 31/4427, A61K 31/433, A61K 31/4245, C07D 513/04, C07D 498/04, A61P 25/00
Applicant:
Ares Trading SA
Agent:
Ulrich Lang, Merck KGaA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13737134

PYRIMIDINE PYRAZOLYL DERIVATIVES

IPC classification:
A61K 31/506, C07D 491/10, C07D 491/08, C07D 487/08, C07D 417/14, C07D 413/14, C07D 407/14, C07D 403/14, C07D 403/04, C07D 401/14, A61P 29/00
Applicant:
Ares Trading SA
Agent:
Ulrich Lang, Merck KGaA
Status:
PATENT GRANTED
EP13729269

FUSED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/4192, C07D 498/04, C07D 487/04, C07D 471/04
Applicant:
Ares Trading SA
Agent:
Ulrich Lang, Merck KGaA
Status:
PATENT GRANTED

Please Sign in to use this feature